Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: Observations with angiography, IVUS and OCT

被引:2
作者
Sakamoto N. [1 ]
Nakazato K. [1 ]
Misaka T. [1 ]
Mizukami H. [1 ]
Kunii H. [1 ]
Suzuki H. [1 ]
Saitoh S.-I. [1 ]
Takeishi Y. [1 ]
机构
[1] Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, 960-1295
关键词
Incomplete stent apposition (ISA); Intravascular ultrasound (IVUS); Neointimal plaque rupture; Sirolimus-eluting stent (SES); Very late stent thrombosis;
D O I
10.1007/s12928-011-0064-1
中图分类号
学科分类号
摘要
Drug-eluting stent (DES) dramatically reduces the incidence of restenosis and rates of target lesion revascularization. Although several reports suggest that very late stent thrombosis could occur in patients after DES implantation, neointimal plaque rupture may be uncommon in the patients treated with DES compared with bare-metal stent. It is unclear that the reason why the patient in acute coronary syndrome (ACS) treated with DES has a high frequency of very late stent thrombosis and pathophysiological mechanisms of neointimal plaque rupture after DES implantation. We report a case of very late stent thrombosis with the findings of neontimal plaque rupture as well as incomplete stent apposition 4 years after sirolimus-eluting stent implantation in ACS. © 2011 Japanese Association of Cardiovascular Intervention and Therapeutics.
引用
收藏
页码:263 / 268
页数:5
相关论文
共 32 条
[1]  
Weisz G., Leon M.B., Holmes Jr. D.R., Kereiakes D.J., Popma J.J., Teirstein P.S., Et al., Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (sirolimus-eluting stent in de novo native coronary lesions) trial, J Am Coll Cardiol, 53, pp. 1488-1497, (2009)
[2]  
Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schoemig A., Et al., Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, pp. 937-948, (2007)
[3]  
Stone G.W., Ellis S.G., Colombo A., Dawkins K.D., Grube E., Cutlip D.E., Et al., Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and BMS implantation, Circulation, 115, pp. 2842-2847, (2007)
[4]  
Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Et al., Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, pp. 1030-1039, (2007)
[5]  
Lee C.W., Kang S.J., Park D.W., Lee S.H., Kim Y.H., Kim J.J., Et al., Intravascular ultrasound findings in patients with very late thrombosis after either drug-eluting or bare-metal stent implantation, J Am Coll Cardiol, 55, pp. 1936-1942, (2010)
[6]  
Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., Et al., Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis, Circulation, 120, pp. 391-399, (2009)
[7]  
Hong M.K., Mintz G.S., Lee C.W., Kim Y.H., Lee S.W., Song J.M., Et al., Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation, Circulation, 109, pp. 881-886, (2004)
[8]  
Daeman J., Tanimoto S., Garcia-Garcia H.M., Kukreja N., van de Sande M., Sianos G., Et al., Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries), Am J Cardiol, 99, pp. 1027-1032, (2007)
[9]  
Fajadet J., Morice M.C., Bode C., Barragan P., Serruys P.W., Wijns W., Et al., Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial, Circulation, 111, pp. 1040-1044, (2005)
[10]  
Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, pp. 1315-1323, (2003)